Antiplatelet Therapy Considerations in Ischemic Cardiogenic Shock
Author:
Affiliation:
1. Department of Pharmacy, Memorial Hermann—Texas Medical Center, Houston, TX, USA
2. Center for Advanced Heart Failure, University of Texas Health Science Center, Houston, TX, USA
Abstract
Publisher
SAGE Publications
Subject
Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology
Link
http://journals.sagepub.com/doi/pdf/10.1177/1074248415571456
Reference53 articles.
1. Temporal Trends in Cardiogenic Shock Complicating Acute Myocardial Infarction
2. Trends in Management and Outcomes of Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock
3. Thirty-Year Trends (1975 to 2005) in the Magnitude of, Management of, and Hospital Death Rates Associated With Cardiogenic Shock in Patients With Acute Myocardial Infarction
4. Long-term Trends in Short-term Outcomes in Acute Myocardial Infarction
5. Early Revascularization in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Clopidogrel, ticagrelor, prasugrel or an alternation of two P2Y12 in patients with acute myocardial infarction with cardiogenic shock;Frontiers in Cardiovascular Medicine;2024-01-03
2. GP IIb/IIIa Receptor Inhibitors in Mechanically Ventilated Patients with Cardiogenic Shock due to Myocardial Infarction in the Era of Potent P2Y12 Receptor Antagonists;Journal of Clinical Medicine;2022-12-14
3. Gut microbiota induces high platelet response in patients with ST segment elevation myocardial infarction after ticagrelor treatment;ELIFE;2022
4. Gut microbiota induces high platelet response in patients with ST segment elevation myocardial infarction after ticagrelor treatment;eLife;2022-03-08
5. One-Year Outcome of Glycoprotein IIb/IIIa Inhibitor Therapy in Patients with Myocardial Infarction-Related Cardiogenic Shock;Journal of Clinical Medicine;2021-10-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3